JP2014521089A5 - - Google Patents

Download PDF

Info

Publication number
JP2014521089A5
JP2014521089A5 JP2014520229A JP2014520229A JP2014521089A5 JP 2014521089 A5 JP2014521089 A5 JP 2014521089A5 JP 2014520229 A JP2014520229 A JP 2014520229A JP 2014520229 A JP2014520229 A JP 2014520229A JP 2014521089 A5 JP2014521089 A5 JP 2014521089A5
Authority
JP
Japan
Prior art keywords
ndpoi
antibody
bead
complex
capture antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014520229A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014521089A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/045886 external-priority patent/WO2013009667A1/en
Publication of JP2014521089A publication Critical patent/JP2014521089A/ja
Publication of JP2014521089A5 publication Critical patent/JP2014521089A5/ja
Pending legal-status Critical Current

Links

JP2014520229A 2011-07-13 2012-07-09 液体試料中のアミロイドベータオリゴマーの検出方法およびその使用 Pending JP2014521089A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161507332P 2011-07-13 2011-07-13
US61/507,332 2011-07-13
PCT/US2012/045886 WO2013009667A1 (en) 2011-07-13 2012-07-09 Method for detection of amyloid beta oligomers in a fluid sample and uses thereof

Publications (2)

Publication Number Publication Date
JP2014521089A JP2014521089A (ja) 2014-08-25
JP2014521089A5 true JP2014521089A5 (https=) 2015-08-27

Family

ID=47506433

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014520229A Pending JP2014521089A (ja) 2011-07-13 2012-07-09 液体試料中のアミロイドベータオリゴマーの検出方法およびその使用

Country Status (13)

Country Link
US (2) US20130052670A1 (https=)
EP (2) EP2732289B1 (https=)
JP (1) JP2014521089A (https=)
KR (1) KR20140072019A (https=)
CN (1) CN103782171B (https=)
AU (1) AU2012282825B2 (https=)
BR (1) BR112014000671A2 (https=)
CA (1) CA2840976A1 (https=)
DK (1) DK2732289T3 (https=)
ES (1) ES2666840T3 (https=)
MX (1) MX2014000480A (https=)
RU (1) RU2014105172A (https=)
WO (2) WO2013009667A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2699827T3 (es) 2009-06-17 2019-02-13 Biogen Ma Inc Composiciones y métodos para la modulación de corte y empalme de SMN2 en un sujeto
US9320793B2 (en) * 2010-07-14 2016-04-26 Acumen Pharmaceuticals, Inc. Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42
WO2014110291A1 (en) 2013-01-09 2014-07-17 Isis Pharmaceuticals, Inc. Compositions and methods for modulation of smn2 splicing in a subject
IL245703B (en) * 2013-11-20 2022-07-01 Univ Iowa Res Found Methods and compositions for treating amyloid deposits
EP3797780B1 (en) 2014-04-17 2022-09-14 Biogen MA Inc. Compositions and methods for modulation of smn2 splicing in a subject
WO2015175769A1 (en) 2014-05-15 2015-11-19 Biogen Ma Inc. Methods for the detection of amyloid beta oligomers in biological samples
US10436802B2 (en) 2014-09-12 2019-10-08 Biogen Ma Inc. Methods for treating spinal muscular atrophy
MA41480A (fr) * 2014-10-17 2017-12-19 Glenmark Pharmaceuticals Sa Anticorps qui se lient au ccr6 et leurs utilisations
EP3341725B1 (en) * 2015-08-25 2021-08-18 Prothena Biosciences Limited Methods for detecting phosphorylated alpha-synuclein
EP3415912B1 (en) 2016-02-08 2023-03-29 Sysmex Corporation Analyte detection method and reagent kit for detecting analyte
US11198867B2 (en) 2016-06-16 2021-12-14 Ionis Pharmaceuticals, Inc. Combinations for the modulation of SMN expression
CN114026109A (zh) * 2019-07-05 2022-02-08 株式会社岛津制作所 β淀粉样蛋白的单克隆抗体、和使用该抗体的β淀粉样蛋白相关肽的测定方法
CN120505310A (zh) 2020-02-28 2025-08-19 Ionis制药公司 用于调节smn2的化合物和方法
WO2022270901A1 (ko) * 2021-06-25 2022-12-29 장재원 동적 형광 또는 x-선의 표준편차와 자기상관을 활용한 조기 진단 시스템
US20240358805A1 (en) * 2021-08-30 2024-10-31 The Brigham And Women's Hospital, Inc. Methods and materials to treat neurodegenerative disease
WO2024026413A2 (en) * 2022-07-27 2024-02-01 Durin Technologies, Inc. Early detection and monitoring of neurodegenerative diseases using a multi-disease diagnostic platform
CN117589996A (zh) * 2022-08-09 2024-02-23 深圳智源生物医药有限公司 强毒性淀粉样蛋白寡聚体的诊断用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665024A (en) 1984-10-01 1987-05-12 Becton, Dickinson And Company Fluorescent gram stain
US6218506B1 (en) 1997-02-05 2001-04-17 Northwestern University Amyloid β protein (globular assembly and uses thereof)
US6082205A (en) 1998-02-06 2000-07-04 Ohio State University System and device for determining particle characteristics
DE60043165D1 (de) 1999-08-04 2009-11-26 Univ Southern California Globularer Aufbau vom Amyloid-beta- protein und deren Verwendungen
CN1871517A (zh) * 2002-02-19 2006-11-29 免疫公司 快速有效分离循环癌细胞的方法和试剂
US7807157B2 (en) 2004-02-20 2010-10-05 Intellect Neurosciences Inc. Monoclonal antibodies and use thereof
JP2008502880A (ja) * 2004-04-02 2008-01-31 メルク エンド カムパニー インコーポレーテッド アミロイド前駆体タンパク質又はβアミロイド断片に結合する物質を検出する方法及び結合化合物
US7572640B2 (en) 2004-09-28 2009-08-11 Singulex, Inc. Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties
US7811563B2 (en) * 2004-10-25 2010-10-12 Northwestern University Anti-addl antibodies and uses thereof
US7731962B2 (en) 2005-02-14 2010-06-08 Merck & Co., Inc. Anti-ADDL monoclonal antibody and use thereof
CN101291692A (zh) * 2005-10-21 2008-10-22 默克制药公司 抗addl单克隆抗体及其应用
US20090181359A1 (en) * 2007-10-25 2009-07-16 Lou Sheng C Method of performing ultra-sensitive immunoassays
CA2779565A1 (en) * 2009-11-24 2011-06-03 Probiodrug Ag Novel diagnostic method for the diagnosis of alzheimer's disease or mild cognitive impairment
WO2011151076A2 (en) * 2010-06-04 2011-12-08 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin MONOCLONAL ANTIBODIES TARGETING Αβ OLIGOMERS
EP2593475B1 (en) * 2010-07-14 2016-03-02 Merck Sharp & Dohme Corp. Anti-addl monoclonal antibody and uses thereof
US9320793B2 (en) * 2010-07-14 2016-04-26 Acumen Pharmaceuticals, Inc. Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42

Similar Documents

Publication Publication Date Title
JP2014521089A5 (https=)
RU2014105172A (ru) Способ обнаружения олигомеров бета-амилоида в образце жидкости организма и варианты его применения
JP2016513094A5 (https=)
JP2020521951A5 (https=)
JP2017184729A5 (https=)
Tang et al. Quantum dots-based sandwich immunoassay for sensitive detection of Alzheimer's disease-related Aβ1–42
JP2017524130A5 (https=)
JP2020517919A5 (https=)
JP2017505897A5 (https=)
JP2013524774A5 (https=)
JP2016118568A5 (https=)
KR20160029869A (ko) 질병의 발달을 모니터링하고 치료의 효율을 평가하기 위한 새로운 바이오마커
JP2017522555A5 (https=)
JP2013543581A5 (https=)
Tüzün et al. Enhanced complement consumption in neuromyelitis optica and Behcet's disease patients
JP2014517308A5 (https=)
Li et al. Artificial Intelligence‐Guided Gut‐Microenvironment‐Triggered Imaging Sensor Reveals Potential Indicators of Parkinson's Disease
Leng et al. mTOR activation induces endolysosomal remodeling and nonclassical secretion of IL-32 via exosomes in inflammatory reactive astrocytes
WO2015048804A3 (en) Protein biomarker and uses thereof
JP6420475B2 (ja) 細気管支炎後の喘息の診断のためのマーカーおよびその用途
EA201490576A1 (ru) Молекулярный маркер для ранней диагностики мезотелиомы плевры у пациентов и способы для анализа его экспрессии
JP2016095233A (ja) 早期肝細胞がん患者の再発リスクの予測を補助する方法、システム及びコンピュータプログラム製品
Nyawira Maranga et al. IL‐6 is upregulated in late‐stage disease in monkeys experimentally infected with Trypanosoma brucei rhodesiense
Steiss et al. Monitoring of omalizumab therapy by measuring free IgE using a bedside immunoassay
JP2012521549A5 (https=)